News
Glioblastoma multiforme is an aggressive brain tumor that mainly affects adults. Approximately 30,000 people in the U.S. are ...
New research from SAHMRI and Flinders University has shed light on how the decades-old antipsychotic drug, trifluoperazine ...
In a study published Wednesday in the Proceedings of the National Academy of Sciences, University of Oklahoma researchers ...
Glioblastoma multiforme is one of the most aggressive and lethal forms of brain cancer, accounting for nearly 15% of all primary brain tumors. Despite conventional treatment options—surgery, radiation ...
Tumor-treating fields (TTFields) therapy and chemoradiation therapy (CRT) may have significant anti-tumor efficacy in ...
1d
News-Medical.Net on MSNZIP4 protein identified as driver of glioblastoma aggressionIn a study published Wednesday in the Proceedings of the National Academy of Sciences (PNAS), University of Oklahoma researchers detail their discoveries about why the brain tumor glioblastoma is so ...
The End Brain ... its innovative therapy, Tumor Treating Fields. Novocure's commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma, non ...
Here’s a look at some of the most recent discoveries from UCLA scientists that are helping to advance more effective and targeted treatment strategies for glioblastoma and other aggressive brain ...
By targeting this enzyme, we can develop more effective treatments for glioblastoma, a brain tumor with very few effective treatment options." Deliang Guo, PhD, study lead author, the founding ...
Brain Tumor Organoids Accurately Model Patient Response to CAR T Cell Therapy Dec. 9, 2024 — Researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results